Jonathan Faison

Most friends know my story, but new followers probably don't - short version: -Am a Wall Street Nobody, started investing in 2008 with no one to teach me & made every mistake in the book (& then some, very lucky to have survived them) -Writing on SA been a hobby for long time…

Solid msg along those lines, if happiness is the goal... youtu.be/0UggoBeCYtU?si…

Coffee at the Close July 11th $XBI $IBB youtu.be/vsv1BqvIaag?si… Always fun to put faces to usernames in Chat, share our thoughts including ideas on radar & what we're learning 👍 $MREO $CAPR $FBIO $ARQT $DAWN $CRMD $PRTA $XENE $NKTR

Applies to $RARE as well, b/c if the combination of pessimism in gene therapy and continued high cash burn along with setrusumab uncertainty takes share price low enough, entry opportunity gets interesting ahead of 2026 catalysts (phase 3 data for GTX-102 + two GTx launches)

$XBI $IBB Been getting asked what our Biotech Chat is like in PMs, prefer posting this here: -Currently 480 members, would still look forward to it every day if we were a fraction of that (great folks, many been trading together since 2018 or before) -Share our positions,…

Despite current uncertainties (China, FDA & interest rates among others), still seems like biotech in the early innings of its next up cycle $XBI $IBB

Goes double for biotech, where cheap is often cheap for a reason $xbi $ibb

Today's W: Taught my cousin's kids to fish a year ago, they just sent me this 😎

A simple reshare helps a lot. Goal= more #profitstopatients Lot of these cancers are highly curable (ie retinoblastoma should have a 90%+ cure rate) Similarly, even in remission, regular check-ups/MRI is key to preventing recurrence (low-hanging fruit we can help them with 👍